Literature DB >> 11514646

Impairments of attention and effort among patients with major affective disorders.

R Cohen1, I Lohr, R Paul, R Boland.   

Abstract

Impairments of attention are common among people with major affective disorders, yet the influence of effortful task demands on attentional performance in unipolar and bipolar illness has been little studied. The authors compared psychiatric inpatients with primary diagnoses of unipolar or bipolar affective disorder (n=27) and age-matched normal control subjects (n=20) on a battery of eight neuropsychological tasks designed to measure different attentional functions. There were low-effort and high-effort versions of each task. Significant group differences were consistently observed on tasks demanding sustained and focused attention, but not on tasks requiring visual selective attention. Although affective disorder patients showed impairments on most tasks regardless of level of task effort, group differences were greatest on high-effort conditions. Results indicate that patients with major affective disorders show significant attentional impairments on most measures of effortful attention, and the magnitude of these impairments increases as the effortful demands of the task increase.

Entities:  

Mesh:

Year:  2001        PMID: 11514646     DOI: 10.1176/jnp.13.3.385

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  17 in total

1.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

2.  The Subjective Value of Cognitive Effort is Encoded by a Domain-General Valuation Network.

Authors:  Andrew Westbrook; Bidhan Lamichhane; Todd Braver
Journal:  J Neurosci       Date:  2019-03-08       Impact factor: 6.167

3.  Neural responses to incongruency in a blocked-trial Stroop fMRI task in major depressive disorder.

Authors:  Toshiaki Kikuchi; Jeffrey M Miller; Noam Schneck; Maria A Oquendo; J John Mann; Ramin V Parsey; John G Keilp
Journal:  J Affect Disord       Date:  2012-09-17       Impact factor: 4.839

Review 4.  Cognitive effort: A neuroeconomic approach.

Authors:  Andrew Westbrook; Todd S Braver
Journal:  Cogn Affect Behav Neurosci       Date:  2015-06       Impact factor: 3.282

5.  Visual short-term memory binding in Alzheimer's disease and depression.

Authors:  Mario A Parra; Sharon Abrahams; Robert H Logie; Sergio Della Sala
Journal:  J Neurol       Date:  2010-02-17       Impact factor: 4.849

6.  Psychoactive medication use and neurocognitive function in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

Authors:  Tara M Brinkman; Nan Zhang; Nicole J Ullrich; Pim Brouwers; Daniel M Green; Deo Kumar Srivastava; Lonnie K Zeltzer; Marilyn Stovall; Leslie L Robison; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2012-07-27       Impact factor: 3.167

Review 7.  Reconstructing and deconstructing the self: cognitive mechanisms in meditation practice.

Authors:  Cortland J Dahl; Antoine Lutz; Richard J Davidson
Journal:  Trends Cogn Sci       Date:  2015-07-28       Impact factor: 20.229

8.  Psychomotor Retardation, Attention Deficit and Executive Dysfunctional in Young Non-hospitalised Un-medicated Non-psychotic Unipolar Depression Patients.

Authors:  Kamini Ramdas Ilamkar
Journal:  J Clin Diagn Res       Date:  2014-02-03

9.  Attention deficit in depressed suicide attempters.

Authors:  John G Keilp; Marianne Gorlyn; Maria A Oquendo; Ainsley K Burke; J John Mann
Journal:  Psychiatry Res       Date:  2008-03-10       Impact factor: 3.222

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.